Navigation Links
Investor Alert - Buyout Of Santarus - Shareholder Rights Law Firm Seeks Higher Price For Santarus Shareholders
Date:11/7/2013

NEW YORK, Nov. 7, 2013 /PRNewswire/ -- Tripp Levy PLLC, a leading securities and shareholder rights law firm, announces that it is investigating the acquisition of Santarus, Inc. (NASDAQ: SNTS) by Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP).  Salix and Santarus announced that the companies have entered into a definitive merger agreement under which Salix will acquire all of the outstanding common stock of Santarus for $32.00 per share in cash.

The investigation concerns whether the board of directors of Santarus breached their fiduciary duties by not engaging in a full and fair process to insure that shareholders obtained the maximum value for their shares.  Indeed, Santarus reported financial and operating results for the quarter and nine months ended September 30, 2013. Key financial results include: Total revenues of $98.8 million grew 81% compared with $54.7 million for the third quarter of 2012; and Net income of $30.3 million, or $0.38 diluted earnings per share (EPS), compared with $9.0 million, or $0.13 diluted EPS for the third quarter of 2012.  Moreover, certain directors and officers of Santarus, who owned approximately 12 percent of Santarus' total outstanding stock have agreed to tender their shares into the offer and vote against any competing bids to acquire Santarus.

If you are a shareholder of Santarus and would like additional information, at no cost, as to how this acquisition may affect your rights as a shareholder, please contact us at:

Tripp Levy PLLC

New York, New York

Toll free:  1-877-772-3975

Email:  contact@tripplevy.com

www.tripplevy.com

Tripp Levy PLLC has extensive experience in mergers and takeovers and has assisted in the recovery of millions of dollars for shareholders around the globe.  Attorney advertising.  Prior results do not indicate a similar outcome.


'/>"/>
SOURCE Tripp Levy PLLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
2. MAP Pharmaceuticals to Present at Upcoming Investor Conferences
3. Gen-Probe Withdraws from Previously Announced Investor Presentations
4. Watson Names Lisa DeFrancesco Vice President, Global Investor Relations
5. Provectus Pharmaceuticals, Inc.s Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
6. Hospira to Present at Upcoming Investor Conferences
7. Heska to Present at B. Riley Investor Conference
8. Parexel Invites Public To Listen To Live Webcast Of Its Investor Day May 31, 2012
9. B. Riley Revises Timing of STAAR Surgical Presentation at Investor Conference
10. CryoLife to Participate in 3rd Annual Benchmark Company, LLC One-on-One Investor Conference
11. STAAR Surgical To Present At The Benchmark And Jefferies Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2017)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ... the development of oral drug delivery systems, announced today ... agreed to schedule an End-of-Phase II meeting with Oramed ... oral insulin capsule ORMD-0801 in the treatment of type ... secondary endpoints by indicating a statistically significant lowering of ...
(Date:7/10/2017)... The Institute for In Vitro Sciences (IIVS), ... of a VITROCELL® inhalation exposure system thanks to a ... device, which is designed to replace animals in inhalation ... to airborne test materials in an environment that mimics ... for testing combustible tobacco products, as well as next ...
(Date:7/10/2017)...  The tenth annual BioPharm America™ will ... at the Sheraton Boston Hotel, September 26–27. The event ... decision makers and innovative biotech startup companies. The event ... two impactful days. BioPharm America is now part of ... opportunities with 4,500+ life science industry influencers participating in ...
Breaking Medicine Technology:
(Date:7/27/2017)... ... July 27, 2017 , ... HIMSS ... will keynote Day 2 of the HIMSS Healthcare Security Forum, the nation’s foremost ... Sheraton Boston Hotel, Sept. 11-13, 2017. , Daniel will deliver his keynote, The ...
(Date:7/26/2017)... ... July 26, 2017 , ... Written By: ... a major advancement in drug therapy for patients living with relapsing and primary ... a novel B cell targeted therapy that has been proven to significantly reduce ...
(Date:7/26/2017)... ... July 26, 2017 , ... A major challenge many labs ... freeze drying samples and a lengthy freeze dry cycle are a few common challenges ... drying techniques, as well as new accessories and advancements in laboratory freeze dryers that ...
(Date:7/26/2017)... ... July 26, 2017 , ... The ... Process Validation and Process Validation Statistics Conferences in Bethesda, Maryland, 12 – ... challenges faced by process validation professionals and statisticians today. , “These conferences ...
(Date:7/26/2017)... (PRWEB) , ... July 26, 2017 , ... Team Type ... access to medicine for everyone affected by diabetes, is excited to announce the 106 ... Global Ambassador Program. , Established in 2005, the Team Type 1 Foundation has ...
Breaking Medicine News(10 mins):